Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in:

Open Access 01-12-2024 | Research

Effect of prophylactic perphenazine on delirium after extubation in severe acute pancreatitis

Authors: Min Chen, Meiling Yu, Dayi Zhang, Ying Chen, Zhitao Yang, Erzhen Chen, Enqiang Mao, Tongtian Ni

Published in: European Journal of Medical Research | Issue 1/2024

Login to get access

Abstract

Background

Severe acute pancreatitis (SAP) is a life-threatening condition that can require invasive mechanical ventilation (IMV) to ensure adequate oxygenation and ventilation. However, IMV can cause delirium, a temporary and fluctuating state of consciousness disorder, which negatively impacts patient outcomes. Perphenazine, an antipsychotic drug that blocks dopamine receptors, can alleviate symptoms such as irritability and restlessness that caused by delirium. This retrospective study aimed to identify risk factors associated with delirium in SAP patients after extubation and withdrawal from IMV, and to determine whether prophylactic use of perphenazine could reduce the incidence of delirium.

Methods

A total of 40 patients with SAP aged 18–75 years who underwent IMV and were successfully extubated offline after treatment were included. Perphenazine was used consistently 2 mg q12 h for 2 days before extubation. The assessment of delirium began after the removal of the endotracheal tube, using Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) every 12 h. Patients were divided into delirium (n = 9) and non-delirium (n = 31) groups or perphenazine (n = 22) and non-perphenazine (n = 18) groups. The clinical data of patients upon admission and after extubation between groups were analyzed using SPSS 26 software. Binary logistic regression was used to evaluate the risk factors for delirium.

Results

Patients with a mean age of 42 years and a male to female ratio of 1.58:1 were enrolled. The incidence of delirium was 22.50%. Univariate analysis (P = 0.025) and binary logistic regression (P = 0.035, 95%CI 0.002–0.762) showed that prophylactic use of perphenazine reduced the incidence of delirium. Fentanyl use was a risk factor for delirium in the univariate analysis (P = 0.039). Patients in the delirium group were hospitalized longer than those in the non-delirium group (P < 0.05).

Conclusion

Perphenazine might have a potential effect on post-extubation delirium in SAP patients.
Literature
1.
Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute pancreatitis. Lancet. 2020;396(10252):726–34.CrossRefPubMed
2.
Ni T, Chen Y, Zhao B, Ma L, Yao Y, Chen E, Zhou W, Mao E. The impact of fluid resuscitation via colon on patients with severe acute pancreatitis. Sci Rep. 2021;11(1):12488.CrossRefPubMedPubMedCentral
3.
Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Acute pancreatitis: diagnosis and treatment. Drugs. 2022;82(12):1251–76.CrossRefPubMedPubMedCentral
4.
Pun BT, Badenes R, La Calle GH, Orun OM, Chen W, Raman R, Simpson BK, Wilson-Linville S, Hinojal Olmedillo B, de la Cueva AV, et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021;9(3):239–50.CrossRefPubMedPubMedCentral
5.
Cortes-Beringola A, Vicent L, Martin-Asenjo R, Puerto E, Dominguez-Perez L, Maruri R, Moreno G, Vidan MT, Fernando A, Bueno H. Diagnosis, prevention, and management of delirium in the intensive cardiac care unit. Am Heart J. 2021;232:164–76.CrossRefPubMed
6.
7.
Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020;89(5):283–306.CrossRefPubMed
8.
Stollings JL, Kotfis K, Chanques G, Pun BT, Pandharipande PP, Ely EW. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 2021;47(10):1089–103.CrossRefPubMedPubMedCentral
9.
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, Tesoro EP, Elswick RK. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44.CrossRefPubMed
10.
Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–10.CrossRefPubMed
11.
Dong Z, Song J, Ge M, Lin C, Zhang J, Chen J, Wu Y. Effectiveness of a multidisciplinary comprehensive intervention model based on the Hospital Elderly Life Program to prevent delirium in patients with severe acute pancreatitis. Ann Palliat Med. 2020;9(4):2221–8.CrossRefPubMed
12.
Wilson JE, Mart MF, Cunningham C, Shehabi Y, Girard TD, MacLullich AMJ, Slooter AJC, Ely EW. Delirium. Nat Rev Dis Prim. 2020;6(1):90.CrossRefPubMed
13.
Hagendorn R, Vincze A, Izbeki F, Gajdan L, Godi S, Illes A, Sarlos P, Farkas N, Eross B, Lillik V, et al. Development of disturbance of consciousness is associated with increased severity in acute pancreatitis. Pancreatology. 2020;20(5):806–12.CrossRefPubMed
14.
Wilcox ME, Girard TD, Hough CL. Delirium and long term cognition in critically ill patients. BMJ. 2021;373: n1007.CrossRefPubMed
15.
Rood PJT, Zegers M, Ramnarain D, Koopmans M, Klarenbeek T, Ewalds E, van der Steen MS, Oldenbeuving AW, Kuiper MA, Teerenstra S, et al. The Impact of nursing delirium preventive interventions in the ICU: a multicenter cluster-randomized controlled clinical trial. Am J Respir Crit Care Med. 2021;204(6):682–91.CrossRefPubMed
16.
Bramley P, McArthur K, Blayney A, McCullagh I. Risk factors for postoperative delirium: an umbrella review of systematic reviews. Int J Surg. 2021;93:106063.CrossRefPubMed
17.
Featherstone I, Sheldon T, Johnson M, Woodhouse R, Boland JW, Hosie A, Lawlor P, Russell G, Bush S, Siddiqi N. Risk factors for delirium in adult patients receiving specialist palliative care: a systematic review and meta-analysis. Palliat Med. 2022;36(2):254–67.CrossRefPubMed
18.
Ke Y, Chew S, Seet E, Wong WY, Lim V, Chua N, Zhang J, Lim B, Chua V, Loh NHW, et al. Incidence and risk factors of delirium in post-anaesthesia care unit. Ann Acad Med Singap. 2022;51(2):87–95.CrossRefPubMed
19.
Oliveira JESL, Berning MJ, Stanich JA, Gerberi DJ, Murad MH, Han JH, Bellolio F. Risk factors for delirium in older adults in the emergency department: a systematic review and meta-analysis. Ann Emerg Med. 2021;78(4):549–65.CrossRef
20.
Han QYC, Rodrigues NG, Klainin-Yobas P, Haugan G, Wu XV. Prevalence, risk factors, and impact of delirium on hospitalized older adults with dementia: a systematic review and meta-analysis. J Am Med Dir Assoc. 2022;23(1):23-32.e27.CrossRefPubMed
21.
Shaw R, Drozdowska B, Taylor-Rowan M, Elliott E, Cuthbertson G, Stott DJ, Quinn TJ. Delirium in an acute stroke setting, occurrence, and risk factors. Stroke. 2019;50(11):3265–8.CrossRefPubMed
22.
Lee M, Kang J, Jeong YJ. Risk factors for post-intensive care syndrome: a systematic review and meta-analysis. Aust Crit Care. 2020;33(3):287–94.CrossRefPubMed
23.
Yamamoto T, Mizobata Y, Kawazoe Y, Miyamoto K, Ohta Y, Morimoto T, Yamamura H. Incidence, risk factors, and outcomes for sepsis-associated delirium in patients with mechanical ventilation: a sub-analysis of a multicenter randomized controlled trial. J Crit Care. 2020;56:140–4.CrossRefPubMed
24.
Kassie GM, Roughead EE, Nguyen TA, Pratt NL, Kalisch Ellett LM. The risk of preoperative central nervous system-acting medications on delirium following hip or knee surgery: a matched case-control study. Drug Saf. 2022;45(1):75–82.CrossRefPubMed
25.
Prendergast NT, Tiberio PJ, Girard TD. Treatment of delirium during critical illness. Annu Rev Med. 2022;73:407–21.CrossRefPubMed
26.
Andersen-Ranberg NC, Poulsen LM, Perner A, Wetterslev J, Estrup S, Hastbacka J, Morgan M, Citerio G, Caballero J, Lange T, et al. Haloperidol for the treatment of delirium in ICU patients. N Engl J Med. 2022;387(26):2425–35.CrossRefPubMed
27.
Khaing K, Nair BR. Melatonin for delirium prevention in hospitalized patients: a systematic review and meta-analysis. J Psychiatr Res. 2021;133:181–90.CrossRefPubMed
28.
Wibrow B, Martinez FE, Myers E, Chapman A, Litton E, Ho KM, Regli A, Hawkins D, Ford A, van Haren FMP, et al. Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial. Intensive Care Med. 2022;48(4):414–25.CrossRefPubMed
29.
Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose nocturnal dexmedetomidine prevents ICU delirium: a randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2018;197(9):1147–56.CrossRefPubMed
30.
Subramaniam B, Shankar P, Shaefi S, Mueller A, O’Gara B, Banner-Goodspeed V, Gallagher J, Gasangwa D, Patxot M, Packiasabapathy S, et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA. 2019;321(7):686–96.CrossRefPubMedPubMedCentral
31.
Thanapluetiwong S, Ruangritchankul S, Sriwannopas O, Chansirikarnjana S, Ittasakul P, Ngamkala T, Sukumalin L, Charernwat P, Saranburut K, Assavapokee T. Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: a randomized double-blind controlled trial. BMC Geriatr. 2021;21(1):215.CrossRefPubMedPubMedCentral
32.
Sadlonova M, Duque L, Smith D, Madva EN, Amonoo HL, Vogelsang J, Staton SC, von Arnim CAF, Huffman JC, Celano CM. Pharmacologic treatment of delirium symptoms: a systematic review. Gen Hosp Psychiatry. 2022;79:60–75.CrossRefPubMed
Metadata
Title
Effect of prophylactic perphenazine on delirium after extubation in severe acute pancreatitis
Authors
Min Chen
Meiling Yu
Dayi Zhang
Ying Chen
Zhitao Yang
Erzhen Chen
Enqiang Mao
Tongtian Ni
Publication date
01-12-2024
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2024
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-024-02158-y

Other articles of this Issue 1/2024

Predictive modeling for acute kidney injury after percutaneous coronary intervention in patients with acute coronary syndrome: a machine learning approach

Lung function and the risk of frailty in the European population: a mendelian randomization study

  • Open Access
  • Research

Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo

Identification of an ADME-related gene for forecasting the prognosis and responding to immunotherapy in sarcomas

Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase

The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysis